November 1, 2016

November is Lung Cancer Awareness Month – Survivor Story

On Connie’s very first day of her first cancer treatment, she read a story about Ernest Hemingway that was in a magazine in the treatment room. A quote from Hemingway stood out to her and she still has this quote in her home today. It read, “You won’t always win, but what is important is to put up a good fight. Never quit, never give up.” Read More


October 29, 2016

Million Dollar Challenge

In the U.S. 1 in 3 women will develop cancer in their lifetime. REVLON partnered with CROWDRISE in a fundraising competition where organizations that support women’s health causes competed for cash prize donations from Revlon. The charity that raised the most money won a $1 Million dollar donation to their cause. During the challenge over $1.4 Million was given away in prize money to organizations participating in the Challenge.
Read More


October 17, 2016

Unlocking the Potential of CAR-T Technology

Since the initial report of ACGT’s researchers success with CAR-T technology in 2012, there has been tremendous interest in the commercial development of the therapy, moving it from lab to practice. An October 3rd Report in Cell and Gene Therapy Insights reviews the current state of CAR-T therapeutics. Read More

The Levis Family with Dr. Savio L.C. Woo, Chairman Emeritus ACGT Scientific Advisory Council

June 3, 2016

Back on Par

In 2012, Bob Levis, an Allentown, Pennsylvania resident, believed he had come to the end of his life. Diagnosed in 2002 with chronic lymphocytic leukemia, … Read More

Lung Cancer

February 26, 2014

Dr. Jack Roth’s Patient with Adenocarcinoma

I am an almost five year survivor of Stage IV NSCLC, adenocarcinoma. I attribute this amazing achievement to the grace of God, aggressive treatment and a “no stone left unturned” attitude. This attitude led me years ago to ACGT and the pioneering work of people like Dr. Jack Roth. Read More

The mission of ACGT is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.

Cell and gene therapies are destroying tumors every day in the laboratory and in human trials, targeting only the cancer with few side effects to healthy tissue.  ACGT’s rigorous grant review process, under the guidance of a preeminent Scientific Advisory Council,  have resulted in some of the most successful breakthroughs in the history of cancer treatments and led to many patients in complete remission.

100% of our funding supports innovation and translational science that is proving again and again to offer better treatment options than the traditional therapies of chemotherapy, surgery and radiation. Every donation brings us closer to saving lives and changing the way we treat cancer forever.